This site is intended for healthcare professionals
News

Full results of EMPEROR-Reduced phase III study of empagliflozin in heart failure.-Eli Lilly + Boehringer

Read time: 1 mins
Last updated:31th Aug 2020
Published:30th Aug 2020
Condition: Heart Failure
Type: drug
Register free for full access to medthority.com